Skip to content

The Standardize Study on Treatment of Obsessive Compulsive Disorder by Acupoint Stimulating.

The Standardize Study on Treatment of Obsessive Compulsive Disorder by Acupoint Stimulating.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000484
Enrollment
Unknown
Registered
2009-07-29
Start date
2009-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive Compulsive Disorder

Interventions

A:acupoint stimulating with medication
B:acupoint stimulating with placebo
C:blank stimulating with medication

Sponsors

Tongde Hospital of Zhejiang Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 60 Years

Inclusion criteria

Inclusion criteria: Meeting the CCMD-3R (Chinese Classification of Mental Disorders, the Third reversion) criteria of diagnosis of OCD; the total scores of Y-BOCS>=16; age range between 16-60; obtaining informed consent.

Exclusion criteria

Exclusion criteria: Other mental disorders which are secondary to obsessive compulsive symptoms; Organic mental disorders (particularly basal ganglia)which are secondary to obsessive compulsive symptoms; The OCD patients with severe function problems of heart, liver and kidney; The OCD patients with primary heart disease; The OCD patients who are currently pregnant; The OCD patients with narrow angle glaucoma.

Design outcomes

Primary

MeasureTime frame
Yale-Brown obsessive-compulsive psychiatrists rating scale(Y-BOCS) and Hamilton anxiety scale (HAMD);blood routine, urine routine, stool routine, liver function, Electrocardiograph (ECG), electroenceph;Treatment Emergent Symptom Scale(TESS);

Countries

China

Contacts

Public ContactBin Feng
fengbintd@yahoo.com.cn+86 0571 89972003

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026